Clinical Trial Update: Study of Photodynamic Therapy (PDT) in Patients With Central Serous Chorioretinopathy (CSC) [Phase 4]

View source ↗

Summary

Phase 4 study evaluating photodynamic therapy for central serous chorioretinopathy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Central Serous Chorioretinopathy

Snippet

Sponsor: Peking University People's Hospital | Conditions: Central Serous Chorioretinopathy | Phase 4 | Status: COMPLETED